Four weeks of sofosbuvir, ledipasvir and ribavirin with or without interferon give high cure rates in drug users with hepatitis C - a randomized controlled trial (4WIDUC)

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato2016
DOI
StatusUdgivet - 2016
BegivenhedAASLD Liver Meeting - USA, Boston, USA
Varighed: 11. nov. 201615. nov. 2016

Konference

KonferenceAASLD Liver Meeting
LokationUSA
LandUSA
ByBoston
Periode11/11/201615/11/2016

Citer dette

@conference{30eafd37442f45ac911963a14d3ab4d2,
title = "Four weeks of sofosbuvir, ledipasvir and ribavirin with or without interferon give high cure rates in drug users with hepatitis C - a randomized controlled trial (4WIDUC)",
author = "Holm, {Anne Lindebo} and Holm, {Dorte Kinggaard}",
note = "Poster 921; null ; Conference date: 11-11-2016 Through 15-11-2016",
year = "2016",
doi = "10.1002/hep.28798",
language = "English",

}

Four weeks of sofosbuvir, ledipasvir and ribavirin with or without interferon give high cure rates in drug users with hepatitis C - a randomized controlled trial (4WIDUC). / Holm, Anne Lindebo; Holm, Dorte Kinggaard.

2016. Poster session præsenteret på AASLD Liver Meeting, Boston, USA.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

TY - CONF

T1 - Four weeks of sofosbuvir, ledipasvir and ribavirin with or without interferon give high cure rates in drug users with hepatitis C - a randomized controlled trial (4WIDUC)

AU - Holm, Anne Lindebo

AU - Holm, Dorte Kinggaard

N1 - Poster 921

PY - 2016

Y1 - 2016

U2 - 10.1002/hep.28798

DO - 10.1002/hep.28798

M3 - Poster

ER -